Results 121 to 130 of about 61,607 (214)

Letermovir for cytomegalovirus prophylaxis in pediatric allogeneic hematopoietic stem cell transplantation: a single-center experience. [PDF]

Blood Res
Tsai PL, Lu MY, Chang HH, Yang YL, Du CJ, Wu CH, Jou ST, Chou SW.   +7 more
europepmc   +1 more source

Personalized tacrolimus therapy in allogeneic hematopoietic stem cell transplantation: from pharmacokinetic variability to novel control strategies. [PDF]

J Pharm Health Care Sci
Yoshikawa N.
europepmc   +1 more source

Breakthrough <i>Magnusiomyces clavatus</i> bloodstream infection with silent dissemination, following allogeneic hematopoietic stem cell transplantation. [PDF]

Med Mycol Case Rep
Nawal A, Lieu A.
europepmc   +1 more source

Allogeneic Hematopoietic Stem Cell Transplantation [PDF]

, 2020
openaire   +1 more source

Metabolomic Signatures of Relapse and Survival in AML Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation. [PDF]

Hematol Rep
Novitzky-Basso I, Xu C, Chiarello C, Reisz JA, D'Alessandro A, Bader GD, Mattsson J, Jones C.   +7 more
europepmc   +1 more source

Time exploration of initiating letermovir for the prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation. [PDF]

Chin Med J (Engl)
Zhang R, Zhu M, Wang L, Liao N, Xie X, Heng J, Cao Y, Hu X, Shi W, Bian Z, Cao W.   +10 more
europepmc   +1 more source

First successful allogeneic hematopoietic stem cell transplantation in STING-associated vasculopathy of infancy-A case report. [PDF]

Mol Ther Adv
Yu U, Song A, Luo C, Luo C, Qin X, Huang X, Wang X, Lin Y, Zhou C, Zhang M, Chen J, Wang X.   +11 more
europepmc   +1 more source

Immune reconstruction after allogeneic hematopoietic stem cell transplantation: rules, mechanisms, and applications. [PDF]

Ann Hematol
Li CM, Wang QY, Chen ZG, Wang CC, Xie YT, Gao L.   +5 more
europepmc   +1 more source

Allogeneic hematopoietic stem cell transplantation for the treatment of chronic active Epstein-Barr virus infection. [PDF]

Cell Transplant
Wang Y, Wu J, Huang X, Xiao Y.
europepmc   +1 more source

Tildrakizumab for the prophylaxis of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. [PDF]

Blood Adv
Runaas L, Fank S, Palen K, Szabo A, Rein LE, Ying G, Salzman N, Samanas L, Abedin S, Chhabra S, Hamadani M, Longo W, Shah NN, Haber J, Gradissimo A, Waters N, Peled JU, Johnson B, Kearl T, Drobyski WR.   +19 more
europepmc   +1 more source